what is the pathology of parkinsons disease?
degeneration of dopamine neurons in the substantia nigra (and other areas; olfactory)
what is parkinsons disease?
- characterised by motor dysfunction and non motor symptoms
where is the highest incidence of parkinsons disease seen and the mean age of onset?
- age of onset = 57
parkinsons involves death of nigrastriatal neurons of the basal ganglia, what is the function of the cells in a non-affected basal ganglia?
2 functions of dopamine
1) transmits signals between the areas in the brain that when working normally coordinate smooth and balanced muscle movement
2) control functions related to mood
what are dopamine precursors and antagonists?
precursors = medication the brain converts to dopamine
antagonists = directly stimulate nerves in the brain that are not naturally being stimulated by dopamine
- have been prescribed to patients and shown some effect
why is the basic circuit in the basal ganglia important?
- causes sustained inhibition to the thalamus
what does wrong in parkinsons?
cells of substantia nigra degenerate - no longer producing adequate amounts of dopamine - neurons of striatum are no longer well regulated and do not behave normally - resulting in symptoms of parkinsons
what are motor symptoms of parkinsons?
1) slow movement
2) tremors
3) muscle rigidity
4) postural change
5) decreased spontaneous movements e.g. blinking
6) gait disorders - slow steps
what are non - motor symptoms of parkinsons?
1) depression
2) bowel problems
3) increased sweating
4) weight loss
5) excess salivation and repsiratory problems
what is a lewy body and effects?
describe treatment of parkinsons with levodopa (L-DOPA)?
describe treatment with dopamine agonists?
what can be give to stop dopamine degradation?
inhibitors
what is thalamotomy surgery?
what is pallidotomy srugery?
- interrupts pathways between globus pallidus and thalamus
what is deep brain stimulation and an advantage?
describe human foetal cell transplantation
where else can you find dopamine producing cells?
pigmented retinal epithelium
what are 2 factors which treatment of parkinsons by PSCs depends on?
1) you can differentiate the PSCs to the correct cell type, ideally efficiently
2) the cell type you make needs to be physiologically mature
how would you manufacture pluripotent stem cells?
either derived from blastocyst or induced pluripotent stem cells
once you have worked out the factors needed to get the correct cells differentiated and you have the neural epithelium what has the happen?
- create cultures of specific part of midbrain where dopaminergic neurons form
2 things which need to be done to make dopaminergic neurons from pluripotent stem cells?
1) supress meso/endoderm differentiation - promote ectoderm
2) inhibit BMP and TGFbeta signalling